SRE
66
3
HP
45
4
BWA
46
2
AXP
69
3
FITB
60
2
PAYX
51
4
WU
30
6
AEP
53
2
GIS
28
2
IPG
53
4
APA
24
3
RL
68
3
UPS
51
10
ABBV
39
8
GILD
49
2
THC
55
-4
DVN
18
2
ALL
51
8
LB
41
7
GLW
46
4
SRE
66
3
HP
45
4
BWA
46
2
AXP
69
3
FITB
60
2
PAYX
51
4
WU
30
6
AEP
53
2
GIS
28
2
IPG
53
4
APA
24
3
RL
68
3
UPS
51
10
ABBV
39
8
GILD
49
2
THC
55
-4
DVN
18
2
ALL
51
8
LB
41
7
GLW
46
4
Financhill
Back

BioLine Rx Vs. Pluri Industry Stock Comparison

Sell
32

BLRX
BioLine Rx

Last Price:
0.33
Seasonality Move:
-0.3%
Sell
41

PLUR
Pluri

Last Price:
4.87
Seasonality Move:
22.76%
Sell
32
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.32. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Pluri (PLUR) is a Sell

Is Pluri a Buy, Sell or Hold?

  • The current Pluri [PLUR] share price is $4.70. The Score for PLUR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • PLUR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing selling pressure, which indicates risk of future bearish movement.

PLUR Stock Price Chart

What is Pluri's stock price today?

  • The Pluri share price today is $4.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUR is experiencing slight selling pressure.

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 32.96 Sell
Chaikin Money Flow: -9838520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.48) Sell
Bollinger Bands (100): (0.47 - 0.73) Sell

PLUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 44.92 Sell
Chaikin Money Flow: -4201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.44 - 5.26) Sell
Bollinger Bands (100): (4.89 - 5.75) Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.46 Sell
20-day SMA: 0.44 Sell
50-day SMA: 0.5 Sell
200-day SMA: 0.73 Sell
8-day EMA: 0.45 Sell
20-day EMA: 0.46 Sell
50-day EMA: 0.5 Sell
200-day EMA: 0.74 Sell

PLUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.28 Sell
20-day SMA: 4.92 Sell
50-day SMA: 5.09 Sell
200-day SMA: 5.7 Sell
8-day EMA: 5.05 Sell
20-day EMA: 5.01 Sell
50-day EMA: 5.08 Sell
200-day EMA: 5.46 Sell

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

Pluri Earnings Growth & PLUR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pluri Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):